← All Sponsors
SPONSOR

Changzhou No.2 People's Hospital

Total Trials
2
Recruiting
2
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Gastric CancerThrombocytopenia Alloimmune
NCT06405113 Phase 2
Recruiting

FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer

Gastric Cancer
China View Trial →
NCT06337474 EARLY_Phase 1
Recruiting

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Thrombocytopenia Alloimmune
China View Trial →